IST:ONCSM (Turkey)
Â
Ordinary Shares
₺
252
+1 (+0.4%)
Jun 26
Business Description
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS
ISIN : TREONCO00026
Share Class Description:
IST:ONCSM: Ordinary SharesTotal Employee Number:
420Description
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is specialized in the production of equipment and medical devices used in cancer treatment.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.36 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.35 | |||||
Debt-to-EBITDA | 0.9 | |||||
Interest Coverage | 4 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 11.99 | |||||
Beneish M-Score | -0.91 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 34.3 | |||||
3-Year EBITDA Growth Rate | 62.1 | |||||
3-Year FCF Growth Rate | -53.1 | |||||
3-Year Book Growth Rate | 22 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 27.3 | |||||
9-Day RSI | 28.14 | |||||
14-Day RSI | 32.99 | |||||
3-1 Month Momentum % | 20.59 | |||||
6-1 Month Momentum % | 9.39 | |||||
12-1 Month Momentum % | 270.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.25 | |||||
Quick Ratio | 1.81 | |||||
Cash Ratio | 0.24 | |||||
Days Inventory | 89.27 | |||||
Days Sales Outstanding | 87.54 | |||||
Days Payable | 32.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -0.56 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 48.94 | |||||
Operating Margin % | 24.01 | |||||
Net Margin % | 6.41 | |||||
EBITDA Margin % | 23.31 | |||||
FCF Margin % | -6.69 | |||||
OCF Margin % | 5.7 | |||||
ROE % | 12.87 | |||||
ROA % | 8.34 | |||||
ROIC % | 25.32 | |||||
3-Year ROIIC % | 31.08 | |||||
ROC (Joel Greenblatt) % | 28.78 | |||||
ROCE % | 26.62 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 132.63 | |||||
PE Ratio without NRI | 124.44 | |||||
PS Ratio | 8.07 | |||||
PB Ratio | 13.44 | |||||
Price-to-Tangible-Book | 13.72 | |||||
Price-to-Operating-Cash-Flow | 141.57 | |||||
EV-to-EBIT | 52.8 | |||||
EV-to-EBITDA | 35.21 | |||||
EV-to-Revenue | 8.21 | |||||
EV-to-FCF | -122.68 | |||||
Price-to-GF-Value | 1 | |||||
Price-to-Graham-Number | 8.71 | |||||
| Price-to-Net-Current-Asset-Value | 33.64 | |||||
Earnings Yield (Greenblatt) % | 1.89 | |||||
FCF Yield % | -0.83 |
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Stock Events
| Event | Date | Price (₺) | ||
|---|---|---|---|---|
| No Event Data | ||||
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS
No articles.